Edition:
United Kingdom

NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines


Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:* Says it and NanoCarrier Co., Ltd <4571.T> conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines .* Under this agreement, Nanocarrier and JCR will integrate the unique technologies and knowledge of both companies, and aim to develop an innovative drug effectively delivered to the brain . 

Company Quote

6240.0
-10.0 -0.16%
5:04am BST